CHAMP Human Microbiome Profiler is now available in the CosmosID-HUBLearn More

The Connection Between Celiac Disease & the Microbiome

12 December 2023by Manoj Dadlani

Celiac Disease, an autoimmune intestinal disorder affecting an estimated 1% of the population, is characterized by the body’s inappropriate response to gluten resulting in damage to the small intestine. Symptoms range widely, from gastrointestinal distress to nutritional deficiencies, and the only current treatment is a rigorous, lifelong gluten-free diet.

The microbiome, on the other hand, refers to the vast community of bacteria and other microbes living in our bodies, particularly in our gut. These tiny organisms play a significant role in our health, from aiding digestion and producing vitamins to regulating our immune system.

This article will explore the intricate relationship between celiac disease and the gut microbiome, uncovering fascinating insights into how our intestinal microbiota might influence the risk of developing celiac disease and whether modulating our microbiome could potentially treat or even prevent the disease.

Understanding Celiac Disease: Symptoms, Causes, and Treatments

Celiac disease is a chronic autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. Gluten is a protein, found in wheat, rye, and barley, that proves harmful for individuals with active celiac disease. 

When people with celiac disease eat gluten, their body mounts an immune response that attacks the small intestine, leading to the damage of villi—tiny projections that line the small intestine and promote nutrient absorption.

Symptoms of celiac disease are extensive and diverse—ranging from gastrointestinal symptoms such as abdominal pain, diarrhea, and bloating, to non-intestinal symptoms like anemia, weight loss, fatigue, and osteoporosis. It’s also important to note that some people with celiac disease may not exhibit any symptoms, but are still at risk of long-term health complications.

The root cause of celiac disease is still not fully understood, but it’s believed to be a combination of genetic and environmental factors. Specifically, studies show that individuals carrying certain genetic variants of the HLA-DQ2 or HLA-DQ8 genes are at higher risk of developing celiac disease. However, not everyone with these genes will develop the condition, thus suggesting the role of additional environmental triggers.

Currently, the only effective treatment for celiac disease is strict, lifelong adherence to a gluten-free diet. This means avoiding any food or drink containing wheat, barley, and rye. This dietary change allows the intestinal lining to heal and alleviate symptoms in most individuals. 

However, it requires substantial patient education, dietetic counseling, and regular follow-up.

Impact of Celiac Disease on Quality of Life

Living with celiac disease significantly affects the quality of life for many patients. The necessity to adhere to a strict gluten-free diet imposes dietary restrictions which can lead to psychosocial distress and negatively impact social life—particularly in children and adolescents.

Through elimination of gluten, most patients experience relief from symptoms and improved health; however, this dietary regimen can be challenging to maintain. 

Additionally, the risk of nutritional deficiencies and potential long-term health complications can cause anxiety and stress among patients. Proactive medical support, patient education, and even counseling can be crucial in helping adult celiac disease patients manage the disease and maintain a good quality of life.

Who is at Risk Of Celiac Disease?

Celiac disease patients can range from infants to adults, and the risk of developing coeliac disease is not limited to any particular age group.

However, there is growing evidence suggesting that specific gut bacteria might trigger the onset of celiac disease in genetically susceptible individuals. Early intestinal microbiota composition in infants, especially during the first months of life, may play a significant role in the development of the disease later in life. 

In celiac patients, the gut microbiome composition often shows an imbalance, or ‘dysbiosis‘, with lower diversity and alterations in the relative abundances of bacterial species. Some studies indicate an overrepresentation of harmful bacteria and a reduction of beneficial bacteria in these patients. 

However, it’s important to note that the relationship between gut bacteria and celiac disease is complex and still not fully understood. 

Is dysbiosis a cause or a consequence of the disease? Could manipulating the gut microbiome, such as through probiotics or dietary changes, prevent or treat celiac disease? Such questions prompt further research into this intriguing field.

The Human Microbiome: A Complex Ecosystem Within Us

The microbiome refers to the collective genomes of the microorganisms residing in an environmental niche. In the context of human health, it predominantly refers to the gut microbiome, a vast and complex community of bacteria, viruses, fungi, and other single-celled organisms living in our digestive tracts.

The gut microbiome serves a host of significant functions — from breaking down food and absorbing nutrients to producing important vitamins and regulating the immune system. It’s also involved in maintaining the integrity of the intestinal barrier, known as “intestinal permeability,” and promoting overall gut health. Furthermore, research indicates that the gut microbiome plays a role in systemic diseases, aligning with the concept that the gut is the “second brain” of the human body.

Understanding the importance of the gut microbiome hinges on the recognition that every individual’s microbiome is unique. Factors such as diet, lifestyle, genetics, and even birth mode (C-section or vaginal delivery) can influence the diversity and composition of the gut microbiome. This variance can impact health outcomes and disease risks, explaining why certain individuals might be more susceptible to conditions like inflammatory bowel disease or celiac disease.

In light of recent scientific findings, the gut microbiome stands as a pivotal player in human health and disease, underscoring the need for further research to unlock its full therapeutic potential. From alleviating gastrointestinal symptoms to potentially altering the course of autoimmune diseases, the gut microbiome holds immense promise in revolutionizing healthcare approaches.

Celiac Disease & Microbiome Connection

“Knowledge about the interplay between diet, microbiota and short-chain fatty acids (SCFAs) so far exists. Moreover, raising evidence suggests their influence on the pathogenesis of celiac disease (CD).”

— Sánchez, E., Ribes-Koninckx, C., Calabuig, M., Sanz, Y. Intestinal Staphylococcus spp. and virulent features associated with coeliac disease. Journal of clinical pathology, 65(9), 830-4. 2012.

Emerging research suggests a substantial link between celiac disease and alterations in the gut microbiome. Numerous studies have reported significant differences in the gut microbiota composition of people with celiac disease compared to healthy individuals. In particular, individuals with celiac disease tend to have a lower diversity of beneficial bacteria and a higher abundance of potentially harmful bacterial species.

One study published in the American Journal of Gastroenterology found that children with celiac disease had greater amounts of harmful bacteria and lesser amounts of beneficial bacteria compared to their non-celiac counterparts. Another study in Clinical and Experimental Immunology revealed that individuals with celiac disease had an overgrowth of bacteria associated with inflammation, such as Bacteroides and Escherichia coli.

The gut microbiome might contribute to the development of celiac disease through several mechanisms. 

  • First, an imbalanced gut microbiome, known as dysbiosis, can disrupt the integrity of the intestinal barrier, leading to increased intestinal permeability. This allows gluten peptides to cross the intestinal barrier, triggering an immune response that results in the characteristic intestinal damage of celiac disease. 
  • Second, certain bacterial species might metabolize gluten differently, generating metabolites that can stimulate the immune system and exacerbate the inflammatory response. 
  • Lastly, the gut microbiome can modulate the immune system directly, and dysbiosis might shift the immune response towards inflammation, contributing to the development and progression of celiac disease.

Despite these intriguing findings, more research is needed to fully understand the complex relationship between the gut microbiome and celiac disease. This could potentially open up new avenues for preventing, diagnosing, and treating this chronic condition.

What is Celiac Disease Pathogenesis?

Pathogenesis is a term used to describe the biological and cellular mechanisms involved in the development of a disease. In the case of celiac disease, pathogenesis refers to the processes that lead to autoimmune reactions against gluten peptides in genetically predisposed individuals.

The onset of celiac disease is thought to be triggered by both environmental and genetic factors. While genetics play an essential role in determining susceptibility, not all individuals with the genetic predisposition will develop celiac disease. This suggests that environmental factors, such as diet and lifestyle, also play a crucial role in celiac disease pathogenesis.

One of these factors could be an imbalance in the gut microbiome. As discussed earlier, dysbiosis has been observed in celiac patients and could potentially contribute to the development of this condition. However, the exact mechanisms and interactions between the gut microbiome and celiac disease pathogenesis are still not fully understood and require further investigation.

Review of Current Research on Microbiome and Celiac Disease

As we have covered above, current research has shed light on the relationship between the gut microbiome and celiac disease, providing substantial evidence that alterations in the gut microbiome, or dysbiosis, may contribute to the onset and progression of this condition. 

However, it’s important to note that these findings are still at a preliminary stage, and the specific mechanisms linking gut microbiota and celiac disease remain to be fully elucidated. 

Current studies predominantly rely on observational and associative data, with a need for more comprehensive, cause-and-effect studies that can further refine our understanding of this complex interplay.

Future Directions for Microbiome and Celiac Disease Research

As the scientific community continues to unravel the mysteries of the gut microbiome, upcoming research is expected to focus on a few key areas. First, there is a growing interest in investigating how modulating the gut microbiome, perhaps through the use of probiotics, prebiotics, or fecal microbiota transplants, could help prevent or treat celiac disease.

Second, advanced genetic techniques might be utilized to identify specific bacterial strains that could play a part in the disease’s pathology. Furthermore, future research may explore the potential of leveraging gut microbes to develop novel diagnostic tools for early detection of celiac disease. 

Potential Development of New Treatments

The promise of microbiome-based therapies is tantalizing. If we can understand how the gut microbiome contributes to celiac disease at a molecular level, we may be able to develop strategies to manipulate the microbiota and counteract disease processes.

This could potentially lead to novel treatments that go beyond the lifelong adherence to a gluten-free diet that is currently the only available therapy for celiac disease. For instance, interventions aiming to restore a healthy gut microbiome, or the use of engineered bacteria that detoxify gluten in the gut, could represent innovative, effective, and patient-friendly treatment alternatives.

However, it’s crucial to stress that these possibilities currently reside in the realm of scientific speculation and require rigorous, evidence-based research to transform them into realistic therapeutic options. 

Summary and Closing Remarks

In this article, we’ve explored the compelling links between the gut microbiome and celiac disease, delving into the current body of research, potential future directions, and the tantalizing promise of new, microbiome-based therapies. Key findings suggest that an imbalance in the gut microbiome, or dysbiosis, may contribute to celiac disease’s onset and progression.

However, the precise mechanisms connecting gut biodiversity and this autoimmune condition remain to be fully elucidated. Future research holds the promise of microbiome modulation techniques, novel diagnostic tools, and innovative treatments, moving beyond the current gluten-free diet-based management of celiac disease.

As we continue researching in this exciting and groundbreaking field, an accurate, comprehensive analysis of the gut microbiome is paramount. We encourage researchers to leverage CosmosID’s state-of-the-art microbiome sequencing platform. It offers an unparalleled depth and precision of microbial identification, empowering you to advance our understanding of the gut microbiome’s role in celiac disease and other autoimmune disorders.

Let’s continue to unlock the mysteries of the human microbiome together, paving the way for innovative strategies in disease prevention, diagnosis, and treatment. Contact us today.

Want more like this? Sign-up to our newsletter to get the latest news from CosmosID:

Manoj Dadlani

Mr. Manoj Dadlani serves as Chief Executive Officer at CosmosID, Inc., the Maryland based provider of industry-leading solutions for unlocking the microbiome. Previously, Mr. Dadlani served as a partner at Applied Value Group, a management consulting and investment firm, and was co-founder and CEO at Rasa Industries, Ltd., a leading beverage manufacturing company. Mr. Dadlani has substantial experience in strategy, M&A, supply chain management, product development, marketing and business development. Mr. Dadlani received his bachelor’s and master’s degrees in Biological Engineering from Cornell University. Services offered by CosmosID’s CLIA certified and GLP laboratory cover the entire workflow from study design to sample collection, extraction, library preparation, sequencing, data analysis and publication support. CosmosID’s cloud-based metagenomics application offers user-friendly access to the largest curated databases for microbial genomics, antimicrobial resistance and virulence data and has been independently validated to return metagenomic analyses at strain level resolution with industry-leading sensitivity and precision.